What does Level Biotechnology Inc. do?

Level Biotechnology Inc. (3118.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 3118.TWO's market cap?

Level Biotechnology Inc. (3118.TWO) has a market capitalization of approximately $1.02 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 3118.TWO pay a dividend?

Yes — Level Biotechnology Inc. (3118.TWO) pays a dividend annually, with a trailing-twelve-month yield of 6.97%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

3118.TWO

Level Biotechnology Inc.

TWO·Biotechnology · Healthcare

NT$31.55NT$0.20−0.63%

Market capNT$1.02B·Aug 27 5:30 AM UTC

Price Chart

NT$31.55−NT$0.20 (−0.63%)today

+5.17%CAGR +1.01%

Select date range

FromTo

Jun 30, 2005Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)6.97%

Annual Dividend (FWD)NT$2.20

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio90.2%

FCF Payout Ratio91.6%

Most Recent DividendNT$2.20

Ex-Dividend DateJun 10

Payment DateJul 3

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)+10.4%

EPS Growth (3Y)+7.0%

EPS Growth (5Y)+1.8%

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$709.37M

Net IncomeNT$76.02M

Net Margin10.7%

Operating Cash FlowNT$93.28M

Capital ExpendituresNT$15.31M

Free Cash FlowNT$77.98M

Return on Equity14.1%

Return on Invested Capital1.8%

Net CashNT$188.00M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 3118.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 3118.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 3118.TWO and 80,000+ other tickers.

About Level Biotechnology Inc.

Level Biotechnology Inc., founded in 1989 and based in New Taipei City, Taiwan, operates in the commercialization and distribution of scientific products and services. The company supplies specialized reagents and consumables for cell culture, immunology, and molecular biology, alongside advanced biomedical instrumentation, throughout Taiwan. Beyond product distribution, Level Biotechnology offers a comprehensive suite of research and testing services. These include expert assessments in mammalian and genetic toxicology, pharmacological studies, biocompatibility testing, and the production of…

CEO: Chun Long Qiu
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 128
Website: www.level.com.tw

Peers

LAUNXP Biomedical Co., Ltd

Cap

NT$823.7M

6814.TWO

Lukas Biomedical Inc.

Cap

NT$799.8M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 3118.TWO

What does Level Biotechnology Inc. do?: Level Biotechnology Inc. (3118.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 3118.TWO's market cap?: Level Biotechnology Inc. (3118.TWO) has a market capitalization of approximately $1.02 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 3118.TWO pay a dividend?: Yes — Level Biotechnology Inc. (3118.TWO) pays a dividend annually, with a trailing-twelve-month yield of 6.97%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.